WallStreetZenWallStreetZen

NASDAQ: KTTA
Pasithea Therapeutics Corp Stock Ownership - Who owns Pasithea Therapeutics?

Insider buying vs selling

Have Pasithea Therapeutics Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Lawrence SteinmanDirector2023-06-0230,000$0.43
$12.93kBuy

1 of 1

KTTA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KTTA insiders and whales buy or sell their stock.

KTTA Shareholders

What type of owners hold Pasithea Therapeutics Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Pd Joint Holdings LLC Series 2016a250.40%2,608,696$19.04MInsider
Eric Shahinian171.66%1,788,415$13.06MInsider
Lawrence Steinman123.07%1,282,174$9.36MInsider
Israel Maxx Abramowitz100.94%1,051,575$7.68MInsider
Avi Geller99.32%1,034,702$7.55MInsider
Dean Lazer86.64%902,600$6.59MInsider
Eric Lazer86.64%902,600$6.59MInsider
Tiago Marques78.63%819,206$5.98MInsider
Yassine Bendiabdallah28.80%300,000$2.19MInsider
David Delaney21.84%227,521$1.66MInsider

1 of 2

KTTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KTTA2.22%97.78%Net Buying
BTTX3.10%88.84%Net BuyingNet Buying
VCNX9.92%90.08%Net BuyingNet Buying
TOVX6.17%1.47%Net Buying
CANF0.02%0.00%

Pasithea Therapeutics Stock Ownership FAQ

Who owns Pasithea Therapeutics?

Pasithea Therapeutics (NASDAQ: KTTA) is owned by 23.88% institutional shareholders, 1,052.71% Pasithea Therapeutics insiders, and 0.00% retail investors. Pd Joint Holdings LLC Series 2016a is the largest individual Pasithea Therapeutics shareholder, owning 2.61M shares representing 250.40% of the company. Pd Joint Holdings LLC Series 2016a's Pasithea Therapeutics shares are currently valued at $19.83M.

If you're new to stock investing, here's how to buy Pasithea Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.